Reply [4]

Hepatology

Volumn 46, Issue 1, 2007, Pages 281-282

  Koda, Masahiko ^a   Murawaki, Yoshikazu ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN;

DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; FIBROINDEX; HEPATITIS C; LETTER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THROMBOCYTE COUNT; VALIDATION PROCESS;

EID: 34547445146     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21730     Document Type: Letter

References (3)

1. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T; MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075.
2. Ikeda K, Saitoh S, Kobayashi M, Suzuki Y, Tsubota A, Suzuki F, et al. Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data. Hepatol Res 2000;18:252-266.
3. Maruyama S, Hirayama C, Horie Y, Yorozu K, Maeda K, Inoue M, et al. Serum immunoglobulins in patients with chronic hepatitis C: A surrogate marker of disease severity and treatment outcome. Hepatogastroenterology 2007;54:493-498.